A novel process for the preparation of n-(4-nitro-2-sulfamoyl-phenyl)-malonamic acid methyl ester and n-(4-amino-2-sulfamoyl-phenyl)-malonamic acid methyl ester
一种丙酰胺酸甲酯、甲磺酰基氨基的技术,应用在制备N-(4-硝基-2-氨磺酰基-苯基)-丙酰胺酸甲酯和N-(4-氨基-2-氨磺酰基-苯基)-丙酰胺酸甲酯的新领域,能够解决生色、颜色问题等问题
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0023] The present invention relates to a new preparation method of the intermediate compound N-(4-methylsulfonylamino-2-sulfamoyl-phenyl)-propionamic acid methyl ester (V), which is used for the preparation of N-(3- {(1R,2S,7R,8S)-3-[(4-fluorophenyl)methyl]-6-hydroxy-4-oxo-3-azatricyclo[6.2.1.0 2,7 ]undec-5-en-5-yl}-1,1-dioxo-1,4-dihydro-1λ 6 ,2,4-Benzothiadiazin-7-yl)methanesulfonamide—trade name celtabvir—a compound used to treat hepatitis C. The present invention also relates to a new intermediate compound for the preparation of the intermediate compound N-(4-methylsulfonylamino-2-sulfamoyl-phenyl)-propionamic acid methyl ester (V), specifically N-(4 -Nitro-2-sulfamoyl-phenyl)-propionamic acid methyl ester (III) and N-(4-amino-2-sulfamoyl-phenyl)-propionamic acid methyl ester (IV).
[0024] The new method of the present invention has two main advantages over the approaches described in US7,939,524 and WO2010 / 42834. The first advantage is that the new route avoids the di...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 